Schistosoma japonicum

Huakang Biomed Announces First Annual Results Since Listing

Loss Reduced, Profit before Tax Excluding Listing Expenses amounted to RMB9.1 Million; Continuous Focus on Research and Development; Lying Strong…

6 years ago